Supernus Pharmaceuticals, Inc. (SUPN)

50.84 -0.96 (-1.85%) USD  |  NASDAQ  |  Jan 15, 13:35
More

Supernus Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Amphastar Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade